ClinicalTrials.gg
Not yet recruitingNCT07930442Updated Nov 12, 2026

Effects of Manual Lymphatic Drainage and Classical Massage on Autonomic and Hemodynamic Responses in Community-Dwelling Older Adults

An interventional study of Manual Lymphatic Drainage Massage and Classical Massage in Autonomic and Hemodynamic Responses in Older Adults, sponsored by Mersin University. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Mersin University · Not applicable, Interventional, and Supportive care

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

**Study Objective**

The aim of this randomized controlled trial is to evaluate the effects of manual lymphatic drainage massage and classical massage on autonomic and hemodynamic responses in community-dwelling older adults aged 60 years and older. The study is expected to contribute to understanding the effects of massage interventions on autonomic and hemodynamic responses and to the development of evidence-based, non-pharmacological interventions supporting older adults' health.

**Study Hypotheses**

Primary Hypothesis (H01): The effects of a single 15-minute session of manual lymphatic drainage massage and classical massage on cardiac autonomic function in community-dwelling older adults differ from those observed in the delayed-intervention control group.

Secondary Hypothesis (H02): The effects of a single 15-minute session of manual lymphatic drainage massage and classical massage on hemodynamic responses in community-dwelling older adults differ from those observed in the delayed-intervention control group.

**Study Design and Procedures**

A total of 75 participants will be randomly assigned to one of three groups: manual lymphatic drainage massage, classical massage, or a delayed-intervention control group.

Participants in the manual lymphatic drainage massage group will receive a single 15-minute session involving gentle, rhythmic massage techniques applied to the neck and supraclavicular regions. Participants in the classical massage group will receive a single 15-minute session involving traditional massage techniques applied to the neck and shoulders. Participants in the delayed-intervention control group will rest for 15 minutes without receiving massage.

Heart rate variability (HRV), heart rate, and blood pressure will be measured before and immediately after the 15-minute massage or rest period in all three groups. HRV measures the natural variation in time between heartbeats and provides information about the regulation of heart function by the autonomic nervous system.

Changes in these measurements will be compared among the three groups to evaluate short-term autonomic and hemodynamic responses.

After completion of the study, participants in the delayed-intervention control group will be offered a massage intervention based on the study findings.

02

Conditions studied

  • Autonomic and Hemodynamic Responses in Older Adults

Keywords

  • Manual Lymphatic Drainage
  • Classical Massage
  • Heart Rate Variability
  • Hemodynamic Responses
  • Autonomic Nervous System
  • Older Adults
03

In context

Lead sponsor

Mersin University is the lead sponsor of 181 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 60 years of age or older.
  • Providing written to participate in the study.
  • Voluntarily participating in the study through Yenişehir Egemenlik Family Health Center, Mezitli Nafiz Çolak Family Health Center, or Yenişehir Mimar Sinan Family Health Center in Mersin, Türkiye.

Exclusion criteria

Exclusion Criteria:

  • Presence of a cardiac pacemaker or implantable cardioverter-defibrillator (ICD).
  • arrhythmias that may affect heart rate variability (HRV).
  • Acute or decompensated heart failure.
  • Acute deep vein thrombosis (DVT) or thrombophlebitis.
  • Acute infection, febrile illness, or active infection in the massage area.
  • Open wounds, active dermatological conditions, hematomas, or impaired skin integrity in the massage area.
  • Cervical disc herniation.
  • Refusal to provide .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Manual Lymphatic Drainage Massage Group

    Participants in this group will receive a single 15-minute manual lymphatic drainage massage session targeting the cervical and supraclavicular regions in the supine position. The massage will follow the basic principles of the Dr. Vodder method, using gentle, rhythmic, superficial pressure and stationary circular movements at a rate of 20-30 movements per minute. Heart rate variability (HRV), heart rate, and blood pressure will be measured before (Z0) and after (Z1) the intervention.

    Other: Manual Lymphatic Drainage Massage

  • Experimental
    Classical Massage Group

    Participants assigned to this group will receive a single 15-minute classical massage session targeting the neck and shoulder regions bilaterally. The massage will begin with gentle, rhythmic effleurage (stroking), followed by petrissage (kneading) and controlled friction movements, and will end with gentle effleurage. Fragrance-free baby oil without colorants, preservatives, or added vitamins will be used. The massage will be performed without causing pain or discomfort. Heart rate variability (HRV), heart rate, and blood pressure will be measured before (Z0) and after (Z1) the intervention.

    Other: Classical Massage

  • No intervention
    Delayed-Intervention Control Group

    Participants assigned to the delayed-intervention control group will not receive any massage intervention during the main study period. They will rest for 15 minutes under the same environmental conditions as the intervention groups. Heart rate variability (HRV), heart rate, and blood pressure will be measured before (Z0) and after (Z1) the rest period, using the same measurement intervals as the intervention groups. After completion of the study, participants will be offered one session of the massage intervention found to be more effective based on the study results.

Interventions

  • OtherManual Lymphatic Drainage Massage

    Participants will be placed in a comfortable supine position with head and neck support. Privacy and hand hygiene will be ensured. Manual lymphatic drainage will follow Dr. Vodder principles, using gentle, rhythmic, superficial pressure without sliding or deep tissue compression. The skin will be gently stretched within its elastic limits and released. Stationary circular movements will be applied from the cervical region toward the supraclavicular terminal area, with very gentle lateral-to-medial movements near the supraclavicular fossa. The massage will last 15 minutes at 20-30 movements per minute, avoiding pain. Afterward, participants will remain supine, be monitored for adverse effects, and undergo post-intervention measurements of heart rate variability (HRV), heart rate, and blood pressure without changing position.

  • OtherClassical Massage

    Before the massage, participants will be positioned comfortably, and the neck and shoulders will be prepared. Privacy and hand hygiene will be ensured. Fragrance-free baby oil without colorants, preservatives, or vitamins will be used, and the hands will be warmed. Classical massage will be applied bilaterally to the neck and shoulders using effleurage (stroking), petrissage (kneading), and friction techniques. The session will begin with gentle, rhythmic effleurage, followed by petrissage of the neck and shoulder muscles and controlled friction over appropriate muscle areas. Gentle effleurage will conclude the session. All movements will avoid pain or discomfort. The massage will last 15 minutes to match the MLD-m intervention duration. Afterward, participants will rest, be monitored for adverse effects, and undergo post-intervention measurements of heart rate variability (HRV), heart rate, and blood pressure.

06

What researchers measure

Primary outcomes

  1. Change in Heart Rate Variability (SDNN)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  2. Change in Heart Rate Variability (RMSSD)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  3. Change in Heart Rate Variability (pNN50)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  4. Change in Heart Rate Variability (LF)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  5. Change in Heart Rate Variability (HF)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  6. Change in Heart Rate Variability (LF/HF Ratio)

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

Secondary outcomes

  1. Change in Heart Rate

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  2. Change in Systolic Blood Pressure

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

  3. Change in Diastolic Blood Pressure

    Time frame: Baseline (Z0) and immediately after the 15-minute massage or rest period (Z1)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Jun 2027, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 12, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07930442
Lead sponsor
Mersin University
Responsible party
Gizem Kalay Çelik (MSc Student, Registered Nurse, Mersin University) — Principal investigator
First posted
Nov 12, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Gizem Kalay Çelik
Contact
gizem.kly@hotmail.com
+905073669252

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion